| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |